Bristol-Myers Squibb
BMY
BMY
1,593 hedge funds and large institutions have $63.5B invested in Bristol-Myers Squibb in 2017 Q1 according to their latest regulatory filings, with 130 funds opening new positions, 616 increasing their positions, 646 reducing their positions, and 118 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
5% less repeat investments, than reductions
Existing positions increased: 616 | Existing positions reduced: 646
9% less capital invested
Capital invested by funds: $69.4B → $63.5B (-$5.93B)
24% less funds holding in top 10
Funds holding in top 10: 59 → 45 (-14)
Holders
1,593
Holding in Top 10
45
Calls
$2.17B
Puts
$1.81B
Top Buyers
| 1 | +$5.06B | |
| 2 | +$364M | |
| 3 | +$358M | |
| 4 |
Renaissance Technologies
New York
|
+$319M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$234M |
Top Sellers
| 1 | -$802M | |
| 2 | -$742M | |
| 3 | -$732M | |
| 4 |
JP Morgan Chase
New York
|
-$226M |
| 5 |
D.E. Shaw & Co
New York
|
-$194M |